OKYO Pharma advances urcosimod to next clinical trial for eye pain
PositiveFinancial Markets

OKYO Pharma has made significant progress by advancing urcosimod to the next stage of clinical trials aimed at treating eye pain. This development is crucial as it highlights the company's commitment to addressing unmet medical needs in ophthalmology, potentially offering relief to patients suffering from chronic eye conditions.
— Curated by the World Pulse Now AI Editorial System